Patent · US Active

Chimeric transmembrane proteins and uses thereof

US12280119B2 · kind B2 · utility

0Cited by

0References

7Claims

0Family size

Assignee

Kite Pharma, Inc. · US

Inventors

Peter Emtage · Lafayette, US
Rosa Vincent · New York, US

Key dates

Filing date	Mar 21, 2019
Grant date	Apr 22, 2025
Priority date	—
Expiry date	Feb 7, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/21
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are chimeric transmembrane proteins, nucleic acids encoding these chimeric transmembrane proteins, and mammalian cells containing these nucleic acids, and methods of making and using these mammalian cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.